Related Articles
Intraoperative Pancreatic Neck Margin Assessment During Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in the Era of Neoadjuvant Therapy: A Multi-institutional Analysis from the Central Pancreatic Consortium
Annals of Surgical Oncology – Data regarding the survival impact of converting frozen-section (FS):R1 pancreatic neck margins to permanent section (PS):R0 by additional resection (i.e.,…
COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report
Journal of Clinical Immunology – The CDC and ACIP recommend COVID-19 vaccination for patients with inborn errors of immunity (IEI). Not much is known about…
Diabetologia | Volume 67, issue 6
Volume 67, issue 6 articles listing for Diabetologia
Advances in Radioligand Theranostics in Oncology
Molecular Diagnosis & Therapy – Theranostics with radioligands (radiotheranostics) has played a pivotal role in oncology. Radiotheranostics explores the molecular targets expressed on tumor…
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum
Annals of Surgical Oncology – Cytoreductive hepatectomy can improve survival and symptoms of hormonal excess in patients with small intestinal neuroendocrine tumor (siNET) liver metastases,…
Journal of Neuro-Oncology | Volume 167, issue 2
Volume 167, issue 2 articles listing for Journal of Neuro-Oncology
Multiple Auer Rod Like Inclusions in Multiple Myeloma
Indian Journal of Hematology and Blood Transfusion –
Characterisation of premature cell senescence in Alzheimer’s disease using single nuclear transcriptomics
Acta Neuropathologica – Aging is associated with cell senescence and is the major risk factor for AD. We characterized premature cell senescence in postmortem brains…
AJCC Cancer Staging System Version 9: Appendiceal Adenocarcinoma
Annals of Surgical Oncology –
A Practical Review of Encorafenib and Binimetinib Therapy Management in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
Advances in Therapy – According to current guidelines, targeted therapy with a combination of BRAF plus MEK inhibitors is the preferred first-line treatment for patients…